Poor Quality SleepQ-SleepNCT06154629
Effect of a Botanical Ingredient in Healthy Subjects With Anxiety and Poor Sleep Quality
A study testing Botanical ingredient in people with Poor Quality Sleep, run by Universidad Católica San Antonio de Murcia at 1 site in Spain.
Trial summary
Randomized, controlled, double-blind, single-center clinical trial with two parallel arms depending on the product consumed (experimental product and placebo product) to analyze the efficacy of a botanical extract in reducing anxiety and improving sleep quality. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Poor Quality Sleep
- What is being tested?
- Botanical ingredient
- Type of treatment
- Pill or oral medicine
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 79 participants
- Where
- 1 siteSpain
- Study dates
- 15 Sep 2023to 29 Jan 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Healthy adults.
- Moderate levels of anxiety by STAI.
- Low sleep quality by PSQI.
- Volunteers able to understand the clinical study and willing to comply with its procedures and requirements.
Who cannot join
- Serious or terminal illness.
- Subjects with body mass index above 32 kg/m2. Pregnant or lactating women.
- Participation in another study involving blood draws or dietary intervention.
- Organic dementias such as Alzheimer's, Huntington's disease, Parkinson's and senile dementia.
- Hypersensitivity to the components of the formula.
- Use of medications that alter cognitive functions or sleep, such as barbiturates, anticonvulsants, benzodiazepines, antidepressants, neuroleptics, alcohol and illicit drugs.
- Subjects with known allergy to some of the study components.
- Inability to understand the informed consent.
Trial locations and contacts
1 site in 1 country.
About this study
Randomized, controlled, double-blind, single-center clinical trial with two parallel arms depending on the product consumed (experimental product and placebo product) to analyze the efficacy of a botanical extract in reducing anxiety and improving sleep quality.
Read the detailed description
Subjects who meet the selection criteria will be randomly assigned to each of the study groups (investigational product dose or placebo, depending on the group to which they have been assigned).
The product to be consumed is a botanical extract. Participants will consume the product for 90 days. They should consume one capsule one hour before going to sleep.
They will make a total of five visits to the research laboratory and the tests preestablished in the protocol will be performed. Subsequently, a statistical analysis will be performed with the variables measured in the study to obtain the results.
- Conditions
- Poor Quality Sleep
- Being tested
- Botanical ingredient, Control group
- Keywords
- botanic extract
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Botanical ingredientDietary supplement
Consumption for 90 days. Subjects should consume one capsule one hour before going to sleep
Control groupDietary supplement
Consumption for 90 days. Subjects should consume one capsule one hour before going to sleep
| Study group | Role | What they receive |
|---|---|---|
| Botanical ingredient | Experimental | Consumption for 90 days. Subjects should consume one capsule one hour before going to sleep Receives: Dietary Supplement: Botanical ingredient |
| Control Group | Placebo comparator | Consumption for 90 days. Subjects should consume one capsule one hour before going to sleep Receives: Dietary Supplement: Control group |
What is being measured
The primary outcome is the main question the study is designed to answer.
Variation in sleep quality from baseline at 12 weeks.
Visual analog scale from 0 to 10. The higher the value, the more quality.
Measured: The evolution of sleep quality after consumption during 12 weeks will be measured.
Secondary outcomes (11)
Change in Sleep Quality from baseline at 12 weeks
Visual analog scale from 0 to 10. The higher the value, the more quality.
Measured: Sleep quality will be measured with a daily scale, from baseline to 12 weeks.
Sleep quality
Measured by Pittsburgh test
Measured: It will be measured twice, once at baseline or at the end of the study after 12 weeks of use
Sleep efficiency
Measured by accelerometry, with Actigraph wGT3X-BT
Measured: It will be measured during 4 working days and one weekend day, before starting the consumption of the product and before the end of consumption (90 days).
Anxiety questionnaire
Test STAI, to measure the level of anxiety of the subjects
Measured: Day 1, at 12 weeks later
Perceived stress scale
Scale Remor, 2001. Test to measure the level of stress of the subjects
Measured: Day 1, at 12 weeks later
Melatonine
It is measured with a blood sample in the early evening.
Measured: It will be measured twice, once at baseline or at the end of the study after 12 weeks of use
Cortisol
Measured with blood sample first thing in the morning.
Measured: It will be measured twice, once at baseline or at the end of the study after 12 weeks of use
Body composition
It is a control variable. Measured by bioimpedance
Measured: The test will be measured at baseline and after 12 weeks of consumption.
Physical activity control
It is a control variable. Measured by Actigraph wGT3X-BT
Measured: It will be measured during 4 working days and one weekend day, before starting the consumption of the product and before the end of consumption (90 days).
Liver safety variables
It is a blood test that measures the presence of some enzymes, proteins and bilirubin in the blood, with the aim of determining if there is any alteration in the liver. Enzyme GPT, GOT, Gamma GT, LDH, alkaline phosphatase and bilirubin (UI/L)
Measured: It will be measured twice, once at baseline or at the end of the study after 12 weeks.
Adverse events
It will be evaluated at each of the visits.
Measured: At 12 weeks after consumption
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Dec 2023
- Study start15 Sep 2023
- Primary completion22 Dec 2023
- Study completion29 Jan 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Poor Quality SleepStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind
- Who is masked
- Participant, Care provider, Investigator, Outcomes assessor
- Enrolment
- 79 participants (actual)
Sponsor and investigators
- Lead sponsor
- Universidad Católica San Antonio de Murcia
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Francisco Javier López Román, Universidad Católica San Antonio de Murcia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06154629
- Sponsor's protocol ID
- UCAMCFE-00034
- Acronym
- Q-Sleep
- Status last verified
- Sep 2023
- First submitted
- 23 Nov 2023
- Last updated
- 16 Feb 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Feb 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of a Botanical Ingredient in Healthy Subjects With Anxiety and Poor Sleep Quality
- ClinicalTrials.gov ID
- NCT06154629
- Acronym / sponsor ID
- Q-Sleep / UCAMCFE-00034
- Conditions
- Poor Quality Sleep
- Keywords
- botanic extract
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 79 participants (actual)
- Lead sponsor
- Universidad Católica San Antonio de MurciaUniversity, hospital or other
- Study start
- 15 Sep 2023 (actual)
- Primary completion
- 22 Dec 2023 (actual)
- Study completion
- 29 Jan 2024 (actual)
- First posted
- 4 Dec 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Randomized, controlled, double-blind, single-center clinical trial with two parallel arms depending on the product consumed (experimental product and placebo product) to analyze the efficacy of a botanical extract in reducing anxiety and improving sleep quality.
Detailed description
Subjects who meet the selection criteria will be randomly assigned to each of the study groups (investigational product dose or placebo, depending on the group to which they have been assigned).
The product to be consumed is a botanical extract. Participants will consume the product for 90 days. They should consume one capsule one hour before going to sleep.
They will make a total of five visits to the research laboratory and the tests preestablished in the protocol will be performed. Subsequently, a statistical analysis will be performed with the variables measured in the study to obtain the results.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind (participant, care provider, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Botanical ingredient | Experimental | Dietary Supplement: Botanical ingredientConsumption for 90 days. Subjects should consume one capsule one hour before going to sleep |
| Control Group | Placebo comparator | Dietary Supplement: Control groupConsumption for 90 days. Subjects should consume one capsule one hour before going to sleep |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Healthy adults.
- Moderate levels of anxiety by STAI.
- Low sleep quality by PSQI.
- Volunteers able to understand the clinical study and willing to comply with its procedures and requirements.
Key exclusion criteria (8 listed)
- Serious or terminal illness.
- Subjects with body mass index above 32 kg/m2. Pregnant or lactating women.
- Participation in another study involving blood draws or dietary intervention.
- Organic dementias such as Alzheimer's, Huntington's disease, Parkinson's and senile dementia.
- Hypersensitivity to the components of the formula.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Botanical ingredientConsumption for 90 days. Subjects should consume one capsule one hour before going to sleep | Dietary supplement | Botanical ingredient |
| Control groupConsumption for 90 days. Subjects should consume one capsule one hour before going to sleep | Dietary supplement | Control Group |
Primary outcome
Variation in sleep quality from baseline at 12 weeks.
Time frame: The evolution of sleep quality after consumption during 12 weeks will be measured.
Visual analog scale from 0 to 10. The higher the value, the more quality.
11 secondary outcomes
Change in Sleep Quality from baseline at 12 weeks
Time frame: Sleep quality will be measured with a daily scale, from baseline to 12 weeks.
Sleep quality
Time frame: It will be measured twice, once at baseline or at the end of the study after 12 weeks of use
Sleep efficiency
Time frame: It will be measured during 4 working days and one weekend day, before starting the consumption of the product and before the end of consumption (90 days).
Anxiety questionnaire
Time frame: Day 1, at 12 weeks later
Perceived stress scale
Time frame: Day 1, at 12 weeks later
Melatonine
Time frame: It will be measured twice, once at baseline or at the end of the study after 12 weeks of use
Cortisol
Time frame: It will be measured twice, once at baseline or at the end of the study after 12 weeks of use
Body composition
Time frame: The test will be measured at baseline and after 12 weeks of consumption.
Physical activity control
Time frame: It will be measured during 4 working days and one weekend day, before starting the consumption of the product and before the end of consumption (90 days).
Liver safety variables
Time frame: It will be measured twice, once at baseline or at the end of the study after 12 weeks.
Adverse events
Time frame: At 12 weeks after consumption
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Feb 2024.
Related trials for Poor Quality Sleep
Recruiting
The Effect of a Daily Magnesium and Melatonin Supplement on Sleep Quality in People With Nighttime Leg Cramps
Poor Sleep Quality, Leg Cramps, Nocturnal
Recruiting
The Impact of Overnight Active Temperature Regulation on the Gut Microbiome, Inflammation, and Circadian Rhythm.
Poor Sleep Quality, Gut Microbiome
Enrolling by invitation
SHLH for Urban Adolescents (Efficacy Trial)
Poor Quality Sleep
Not yet recruiting
Effects of Daily Avocado Consumption on Sleep and Skin Health in Postmenopausal Females
Poor Sleep Quality
Not yet recruiting
Improving Sleep Health for Asian Americans
Poor Sleep Quality, Short Sleep
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Botanical ingredient in people with Poor Quality Sleep, run by Universidad Católica San Antonio de Murcia at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Variation in sleep quality from baseline at 12 weeks. (time frame: The evolution of sleep quality after consumption during 12 weeks will be measured.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Feb 2024.